Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Neurology. Genetics|June 29, 2026
Preparing Amyotrophic Lateral Sclerosis Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk VariantsJennifer Morganroth, Julia Yasek, Matthew Harms
Neurology. Clinical Practice|October 14, 2024
Anti-Myelin-Associated Glycoprotein Neuropathy: Recent DevelopmentsJennifer Morganroth, Chafic Karam
The Neurohospitalist|August 29, 2013
Inpatient management of guillain-barré syndromeMatthew Harms
Nature Medicine|October 9, 2013
Brown and beige fat: development, function and therapeutic potentialMatthew Harms, Patrick Seale
The FEBS Journal|July 5, 2020
The colorful versatility of adipocytes: white-to-brown transdifferentiation and its therapeutic potential in humansStefanie Maurer, Matthew Harms, Jeremie Boucher
Neurology. Clinical Practice|June 10, 2024
Enhancing Clinical Infrastructure for the Delivery of Intrathecal and Genetic Therapies: A Qalsody (Tofersen) Model for Patients With SOD1-ALSJennifer Morganroth, Tanya M Bardakjian, Laynie Dratch, et al.
Muscle & Nerve|July 2, 2013
Cramps and small-fiber neuropathyGlenn Lopate, Elizabeth Streif, Matthew Harms, et al.
Neurology. Clinical Practice|June 26, 2024
Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United StatesJennifer Morganroth, Leah Zuroff, Amanda C Guidon, et al.
Genetic Epidemiology|November 28, 2023
DYNATE: Localizing rare-variant association regions via multiple testing embedded in an aggregation treeXuechan Li, John Pura, Andrew Allen, et al.
Molecular and Cellular Biology|June 3, 2015
The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by InsulinLisa M DiPilato, Faiyaz Ahmad, Matthew Harms, et al.
Pageof 4